Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


28.11.2022

2 J Neurosci
4 Lancet Neurol
2 Mov Disord
1 Neurochem Res
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    J Neurosci

  1. OTERO PA, Fricklas G, Nigam A, Lizama BN, et al
    Endogenous PTEN-Induced Kinase 1 Regulates Dendritic Architecture and Spinogenesis.
    J Neurosci. 2022;42:7848-7860.
    PubMed         Abstract available

  2. KEIFMAN E, Coll C, Tubert C, Paz RM, et al
    Preserved Motility after Neonatal Dopaminergic Lesion Relates to Hyperexcitability of Direct Pathway Medium Spiny Neurons.
    J Neurosci. 2022;42:8767-8779.
    PubMed         Abstract available


    Lancet Neurol

  3. SOILEAU MJ, Aldred J, Budur K, Fisseha N, et al
    Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial.
    Lancet Neurol. 2022;21:1099-1109.
    PubMed         Abstract available

  4. RIZIG M, Thomas O
    A health literacy campaign for Parkinson's disease in Africa: a novel campaign to break down language barriers.
    Lancet Neurol. 2022;21:1081-1082.
    PubMed        

  5. OBESO JA, Monje MHG, Matarazzo M
    Major advances in Parkinson's disease over the past two decades and future research directions.
    Lancet Neurol. 2022;21:1076-1079.
    PubMed        

  6. FOX SH
    Revisiting levodopa for advanced Parkinson's disease.
    Lancet Neurol. 2022;21:1063-1065.
    PubMed        


    Mov Disord

  7. DARMANI G, Drummond NM, Ramezanpour H, Saha U, et al
    Long-Term Recording of Subthalamic Aperiodic Activities and Beta Bursts in Parkinson's Disease.
    Mov Disord. 2022 Nov 24. doi: 10.1002/mds.29276.
    PubMed         Abstract available

  8. TALEBI AH, Ypinga JHL, De Vries NM, Nonnekes J, et al
    Specialized Versus Generic Allied Health Therapy and the Risk of Parkinson's Disease Complications.
    Mov Disord. 2022 Nov 24. doi: 10.1002/mds.29274.
    PubMed         Abstract available


    Neurochem Res

  9. ZHOU S, Zhou X, Jiang Z, Ma J, et al
    The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2022 Nov 18. doi: 10.1007/s11064-022-03795.
    PubMed         Abstract available


    PLoS One

  10. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0278279.
    PubMed         Abstract available

  11. JOLA C, Sundstrom M, McLeod J
    Benefits of dance for Parkinson's: The music, the moves, and the company.
    PLoS One. 2022;17:e0265921.
    PubMed         Abstract available

  12. DIERIKS BV, Highet B, Alik A, Bellande T, et al
    Human pericytes degrade diverse alpha-synuclein aggregates.
    PLoS One. 2022;17:e0277658.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: